Aina Karen Anthi

8PUBLICATIONS
61CO-AUTHORS
Environmental epidemiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityNanomedicinePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 29, 2026
A human erythropoietin-albumin fusion protein tailored for enhanced plasma half-life and delivery across mucosal surfaces.

|Aug 14, 2026
Fusion of IgG antibodies to albumin inhibits transport across the placenta.

|May 01, 2025
An intranasal subunit vaccine induces protective systemic and mucosal antibody immunity against respiratory viruses in mouse models.

Aina Karen Anthi, Anette Kolderup, Eline Benno Vaage

|Mar 07, 2024
Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria.

Stian Foss, Siri A Sakya, Leire Aguinagalde

|Dec 11, 2023
A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery.

Sopisa Benjakul, Aina Karen Anthi, Anette Kolderup

|Dec 30, 2022
Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants.

Trung The Tran, Eline Benno Vaage, Adi Mehta

Pageof 2

Frequent Collaborators

6 joint publications

Jan Terje Andersen

4 joint publications

Sopisa Benjakul

4 joint publications

Torleif Tollefsrud Gjølberg

3 joint publications

Lisa Tietze